RT Journal Article SR Electronic T1 Network biology and bioinformatics-based framework to identify the impacts of SARS-CoV-2 infections on lung cancer and tuberculosis JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.09.10.24313452 DO 10.1101/2024.09.10.24313452 A1 Waaje, Abdul A1 Sarkar, Md Sumon A1 Islam, Md Zahidul YR 2024 UL http://medrxiv.org/content/early/2024/09/12/2024.09.10.24313452.abstract AB The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a coronavirus variation responsible for COVID-19, the respiratory disease that triggered the COVID-19 pandemic. The primary aim of our study is to elucidate the complex network of interactions between SARS-CoV-2, tuberculosis, and lung cancer employing a bioinformatics and network biology approach. Lung cancer is the leading cause of significant illness and death connected to cancer worldwide. Tuberculosis (TB) is a prevalent medical condition induced by the Mycobacterium bacteria. It mostly affects the lungs but may also have an influence on other areas of the body. Coronavirus disease (COVID-19) causes a risk of respiratory complications between lung cancer and tuberculosis. SARS-CoV-2 impacts the lower respiratory system and causes severe pneumonia, which can significantly increase the mortality risk in individuals with lung cancer. We conducted transcriptome analysis to determine molecular biomarkers and common pathways in lung cancer, TB, and COVID-19, which provide understanding into the association of SARS-CoV-2 to lung cancer and tuberculosis. Based on the compatible RNA-seq data, our research employed GREIN and NCBI’s Gene Expression Omnibus (GEO) to perform differential gene expression analysis. Our study exploited three RNA-seq datasets from the Gene Expression Omnibus (GEO)—GSE171110, GSE89403, and GSE81089—to identify distinct relationships between differentially expressed genes (DEGs) in SARS-CoV-2, tuberculosis, and lung cancer. We identified 30 common genes among SARS-CoV-2, tuberculosis, and lung cancer (25 upregulated genes and 5 downregulated genes). We analyzed the following five databases: WikiPathway, KEGG, Bio Carta, Elsevier Pathway and Reactome. Using Cytohubba’s MCC and Degree methods, We determined the top 15 hub genes resulting from the PPI interaction. These hub genes can serve as potential biomarkers, leading to novel treatment strategies for disorders under investigation. Transcription factors (TFs) and microRNAs (miRNAs) were identified as the molecules that control the differentially expressed genes (DEGs) of interest, either during transcription or after transcription. We identified 35 prospective therapeutic compounds that form significant differentially expressed genes (DEGs) in SARS-CoV-2, lung cancer, and tuberculosis, which could potentially serve as medications. We hypothesized that the potential medications that emerged from this investigation may have therapeutic benefits.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at GSE171110, GSE89403, and GSE81089. https://www.ncbi.nlm.nih.gov/gds